Dr. Reddy's Laboratories Rises Monday, Outperforms Competitors

Dow Jones10-12 18:31

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Dr. Reddy's Laboratories Ltd. rose 2.96% to 1,230.50 Indian rupees Monday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index falling 0.76% to 71,924.68.

Dr. Reddy's Laboratories Ltd. closed 13.00% short of its 52-week high of 1,414.40 rupees, which the company reached on June 29th.

The stock outperformed some of its competitors Monday, as Lupin Ltd. fell 1.10% and Zydus Lifesciences Ltd. rose 1.51%. Wockhardt Ltd. fell 1.66%.

Trading volume totaled 110,740, compared to the 50-day average of 96,311.

Data source: Dow Jones Market Data, FactSet

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment